2022 June

IDO1 inhibitors

Recently Disclosed IDO1 Inhibitors

Abnormally high expression of indoleamine 2, 3-dioxygenase 1 (IDO1) is closely related to tumor immune escape and is an important target of tumor immunotherapy. In-depth research on the structure and […]

Imidazoline quinolones

Advances in mTOR Inhibitors

A mass of studies have revealed that mTOR is a serine/threonine protein kinase closely related to the occurrence of A mass of studies have revealed that mTOR is a serine/threonine […]

drug

Approved Carbohydrate-based Drugs During 2000-2021

As the basic substance of life, carbohydrate molecules participate in almost all aspects of life activities and play various important biological functions. Based on the extensive biological functions of carbohydrate, […]